
Kova Review
GLP-1 weight-loss telehealth · Independently scored 5.4/10
Best for: seeing what it charges before you answer any medical questions
Kova rates best on getting signed up and staying signed up.
then $299/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Read the $129 carefully: it applies to the first month and nothing after. What you actually pay is $449 for each 4 weeks on the 1-month plan, or $329 and $299 per 4 weeks if you take the 3- or 6-month one. A Delaware company, LifeTech Apps Inc, is behind it, and an app rides along tracking side effects, protein intake and weight. Delivery, the compounded GLP-1 and clinician review all sit inside the one plan price.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to Kova
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Kova at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $129/mo (FAQ verbatim: 'Intro month (1st 4 weeks only): $129, renewal (every 24 weeks): $1794 ($299/4 weeks)'. The $129 headli...)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How Kova scores
Six columns, each one computed from something Kova has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
3.0/10The figures published here are not comparable monthly cash prices for the medication — an insured copay, a per-vial rate, a membership fee or a starting-dose teaser. Capped rather than scored against the register.
Effectiveness25%
5.0/10The published price list names no GLP-1 we can match to a pivotal trial, so the medications on offer cannot be scored on evidence.
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
6.5/10does not name a dispensing pharmacy; shows a price before asking for health information. Our verification confidence is medium.
Accessibility10%
5.0/10Publishes no list of states served, so coverage cannot be confirmed either way. Capped at the midpoint — this measures disclosure, not reach.
Support10%
7.0/10The price covers medication, consult, shipping.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on Kova
Last checked August 2026- Re-read the price on file across 3 dose or plan tiers
- Established what the monthly figure covers, and what it leaves out
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
What signing up with Kova involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1Kova publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3Kova does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
- 4The monthly price is recorded as covering medication, consult, shipping.
- No comparable monthly cash price for the medication is on record — either nothing is published, or what is published is a fee, an insured copay or a per-vial rate rather than a monthly cost.
- No state list is published, so whether Kova serves your state cannot be confirmed from its site.
Kova support, as documented
- support@trykova.com
Pricing
Prices re-verified
Standing renewal rate published in the site FAQ: 'Intro month (1st 4 weeks only): $249, renewal (every 4 weeks): $449'. Billed per 4 WEEKS, not per calendar month — 13 charges a year rather than 12. Bundle includes clinician review, medication, delivery and the companion app; there is no separate medication charge. The specific GLP-1 molecule is never named on the site.
FAQ verbatim: 'Intro month (1st 4 weeks only): $149, renewal (every 12 weeks): $987 ($329/4 weeks)'.
FAQ verbatim: 'Intro month (1st 4 weeks only): $129, renewal (every 24 weeks): $1794 ($299/4 weeks)'. The $129 headline used in marketing is this intro month only.
Check the price yourself before you pay
Every figure here was read off Kova's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly figure covers medication, consult, shipping
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- No state list is on record here, so whether it serves your state cannot be confirmed from this page
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
What Kova charges
The figure Kova leads with is $129, and it is a first-month rate. From month two the price is $299/month, which is the number to plan around. Nothing improper about an introductory offer — it just is not the price of staying on the medication.
- 1-month plan, billed every 4 weeks — $249 first month, then $449/month
- 3-month plan, billed every 12 weeks — $149 first month, then $329/month
- 6-month plan, billed every 24 weeks — $129 first month, then $299/month
The median standing price across the GLP-1 providers we track is about $169/month, so this is a premium, and a premium has to buy something. Discounting the first month does not change the twelve-month total by much.
What we could verify
Kova publishes little that can be checked from outside an intake. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You are optimizing for the twelve-month total rather than the first bill — a flat-rate seller will usually win that arithmetic.
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will be paying in month three.
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- you want a cheap way to find out whether the medication suits you before committing
Our read
Kova is a cheap way to start and an ordinary way to continue. Use the $129 month for what it is good for — establishing whether the medication works for you — and re-run the numbers against $299/month before you let it renew twice.
The Bottom Line
Kova rates best on getting signed up and staying signed up.
Before you pay Kova
Starting at $129/month. Check today's price, then book the free consultation.
Where Kova is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Kova review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
See Kova's current pricing
Plans start at $129/month. The free consultation is where you learn whether you qualify, and what it costs today.